2024
European Society for Medical Oncology ESMO Congress 2024
Sept 13-17, 2024
Location: Barcelona, SP
Name: Luna Zhan
Abstract Title: Age, performance status, comorbidity, and disease burden in Canadian patients (pts) with advanced EGFR-mutated lung cancer treated with first-line osimertinib (CARMA-BROS study)
Type: Not yet accepted
Name: Samir Bargout
Abstract Title: Predictors of poor Progression-Free Survival (PFS) in real-world patients (pts) with EGFR-mutations treated with first-line osimertinib.
Type: Not yet accepted
Name: Sze Wah Samuel Chan
Abstract Title: Patterns of care post-first line osimertinib in Canadian EGFR-mutated patients (pts) in the real-world setting: implications for MARIPOSA-2 and other post-osimertinib trials.
Type: Not yet accepted
IASLC, 2024 World Conference on Lung Cancer (WCLC)
Sept 7-10, 2024
Location: San Diego, CA
Name: Elizabeth Faour
Abstract Title: Age, health utility scores (HUS) and survival outcomes in EGFR-mutated lung cancer receiving 1L TKI treatment
Type: ePoster - withdrawn
Name: Sameena Khan
Abstract Title: International consortium real-world outcomes in extensive disease small cell lung cancer compared to IMPOWER133 and CASPIAN
Type: ePoster
Name: Sameena Khan
Abstract Title: 30 years of international real-world outcomes in patients with limited disease small cell lung cancer
Type: Mini Oral
Name: Vicky Mai
Abstract Title: Oligoprogression and osimertinib continuation post-progression in patients with EGFR-mutations.
Type: Poster
University of Toronto, Division of Medical Oncology Research Day, Princess Margaret Cancer Centre
Friday, June 21, 2024
Location: Toronto
Name: Sameena Khan
Abstract Title: Novel genome-wide significant germline genetic variants associated with venous thrombo-embolism (VTE) and arterial embolism (ATE) risk in patients with ALK and ROS1 fusion non-small cell lung cancer (NSCLC).
Type: N/A
American Society of Clinical Oncology Annual Meeting
May 31-June 4, 2024
Location: Chicago
Name: Sameena Khan
Abstract Title: Novel genome-wide significant germline genetic variants associated with venous thrombo-embolism (VTE) and arterial embolism (ATE) risk in patients with ALK and ROS1 fusion non-small cell lung cancer (NSCLC).
Division of Hematology Academic Day (U Toronto)
Location: Toronto
Name: Sameena Khan
Abstract Title: Novel genome-wide significant germline genetic variants associated with venous thrombo-embolism (VTE) and arterial embolism (ATE) risk in patients with ALK and ROS1 fusion non-small cell lung cancer (NSCLC).
Type: Poster
Award: Best Poster